Keywords: ph, iib, trial, isotechnika, isa247, opens, canadian

Ph IIb trial of Isotechnika's ISA247 opens

Article | 16 January 2006

Print This

Canadian drugmaker Isotechnika has enrolled its first patient in a North American Phase IIb kidney transplant trial for its lead ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in